NCT06091566 - Safety and Performance of UCon Bar Electrode for the Treatment of Overactive Bladder (OAB) and Bowel Dysfunction (BD) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 12, 2024

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2026

Conditions

Urinary IncontinenceUrinary Incontinence, UrgeFecal IncontinenceFecal Incontinence With Fecal UrgencyNocturiaUrinary Frequency More Than Once at NightBowel Disorders FunctionalIncontinence, Nighttime Urinary

Interventions

DEVICE

UCon-Bar

The participant self-administer electrical stimulation to the dorsal genital nerve (DGN) for either 4 weeks or 12 weeks using UCon with the Bar electrode

Trial Locations (3)

2730

RECRUITING

Herlev Hospital, Herlev

5000

RECRUITING

Odense University Hospital, Odense

8200

RECRUITING

Aarhus University Hospital, Aarhus